Hao, Haiping

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 705

Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cells

Kim, Y., Sharov, A. A., McDole, K., Cheng, M., Hao, H., Fan, C.-M., Gaiano, N., Ko, M. S. H., & Zheng, Y. (2011) · Science

Nuclear Structure and FunctionPluripotent Stem Cells Research

Cited by 247

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis

Zhou, J., Cui, S., He, Q., Guo, Y., Pan, X., Zhang, P., Huang, N., Ge, C., Wang, G., Gonzalez, F. J., et al. (2020) · Nature Communications

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 154

Wnt/β-Catenin Signaling in Liver Cancers

Wang, W., Smits, R., Hao, H., & He, C. (2019) · Cancers

Wnt/β-catenin signaling in development and cancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 143

Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis

Zhou, J., Huang, N., Guo, Y., Cui, S., Ge, C., He, Q., Pan, X., Wang, G., Wang, H., & Hao, H. (2019) · Acta Pharmaceutica Sinica B

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 99

Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis

Wang, H., Ge, C., Zhou, J., Guo, Y., Cui, S., Huang, N., Yan, T., Cao, L., Che, Y., Zheng, Q., et al. (2018) · EBioMedicine

Liver physiology and pathologyCell death mechanisms and regulation

Cited by 55